Neovasc (NVCN) Misses Q3 EPS by 60c

Neovasc (NASDAQ: NVCN) reported Q3 EPS of ($3.00), $0.60 worse than the analyst estimate of ($2.40). Revenue for the quarter came in at $923 thousand versus the consensus estimate of $1.05 million.

For earnings history and earnings-related data on Neovasc (NVCN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c